The IMA Group strengthens its presence in the pharma and consumer goods sectors On August 1st 2024, IMA Group, through the new established IMA Sarong, completed the closing for the acquisition of the…
The life science group Sartorius and Repligen Corporation today announced the launch of an integrated bioreactor system that incorporates Repligen XCell® ATF upstream intensification technology into Sartorius’ Biostat STR® bioreactor, simplifying intensified…